Deciphering the Critical Pathways of Mutant N-RAS in AML Using Small Molecule Inhibitors

被引：0
|
作者：
Nonami, Atsushi [1 ]
Sattler, Martin [1 ]
Weisberg, Ellen L. [1 ]
Liu Qingsong
Zhang, Jianming
Adelmant, Guillaume
Marto, Jarrod A.
Kohl, Nancy [2 ]
Kung, Andrew L. [2 ]
Sim, Taebo [3 ]
Gray, Nathanael S.
Griffin, James D.
机构：
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Lurie Family Imaging Ctr, Boston, MA USA
[3] Korea Inst Sci & Technol, Taejon, South Korea
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.2455.2455
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2455
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Using Small Molecules To Identify Critical Signaling Pathways Of Mutant N-RAS In Acute Leukemia Cells
    Nonami, Atsushi
    Sattler, Martin
    Weisberg, Ellen L.
    Zhang, Jianming
    Liu, Qingsong
    Patricell, Matthew
    Yoon, Hojong
    Christie, Amanda L.
    Sauer, Amy M.
    Kohl, Nancy
    Kung, Andrew L.
    Sim, Taebo
    Gray, Nathanael S.
    Griffin, James D.
    BLOOD, 2013, 122 (21)
  • [2] SSCP DETECTION OF N-RAS PROMOTER MUTATIONS IN AML PATIENTS
    THORN, J
    MOLLOY, P
    ILAND, H
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (10) : 1098 - 1103
  • [3] Development of mutant-specific small molecule inhibitors of K-Ras.
    Ostrem, Jonathan M.
    Peters, Ulf
    Ren, Pingda
    Lu, Yi
    Wells, James A.
    Shokat, Kevan M.
    CANCER RESEARCH, 2013, 73 (08)
  • [4] MUTATIONAL ACTIVATION OF THE N-RAS ONCOGENE ASSESSED IN PRIMARY CLONOGENIC CULTURE OF ACUTE MYELOID-LEUKEMIA (AML) - IMPLICATIONS FOR THE ROLE OF N-RAS MUTATION IN AML PATHOGENESIS
    BASHEY, A
    GILL, R
    LEVI, S
    FARR, CJ
    CLUTTERBUCK, R
    MILLAR, JL
    PRAGNELL, IB
    MARSHALL, CJ
    BLOOD, 1992, 79 (04) : 981 - 989
  • [5] DISTINCT SPECTRUM OF N-RAS MUTATIONS IN AML AND MDS PATIENTS IN YUGOSLAVIA
    KRTOLICA, K
    UROSEVIC, N
    NESIC, D
    TUKIC, L
    DIMITRIJEVIC, B
    DUJIC, A
    ONCOLOGY REPORTS, 1994, 1 (03) : 619 - 623
  • [6] Targeted depalmitoylation of N-Ras for suppression of oncogenic signaling pathways
    Vora, Hetika
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [7] Paired human fibrosarcoma cell lines that possess or lack endogenous mutant N-ras alleles as experimental model for Ras signaling pathways
    Gupta, S
    Stanbridge, EJ
    REGULATORS AND EFFECTORS OF SMALL GTPASES, PT G, 2001, 333 : 290 - 306
  • [8] Small-molecule inhibitors of mutant RAS-effector protein interactions derived using an intracellular antibody fragment
    Rabbitts, Terry
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [9] Identification and characterization of small molecule inhibitors that radiosensitize K-RAS mutant rectal cancers
    Kleiman, Laura B.
    Krebs, Angela
    Kim, Stephen
    Hong, Theodore S.
    Haigis, Kevin M.
    CANCER RESEARCH, 2013, 73 (08)
  • [10] Targeted genetic and small molecule disruption of N-Ras CaaX cleavage alters its localization and oncogenic potential
    Hildebrandt, Emily R.
    Hussain, Shaneela A.
    Sieburg, Michelle A.
    Ravishankar, Rajani
    Asad, Nadeem
    Gore, Sangram
    Ito, Takahiro
    Hougland, James L.
    Dore, Timothy M.
    Schmidt, Walter K.
    BIOORGANIC CHEMISTRY, 2024, 147
12345